Temporal arteritis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(14 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Temporal arteritis}}
{{Temporal arteritis}}
{{CMG}}
{{CMG}}; {{AE}} {{HQ}}


==Overview==
==Overview==
Incidence of temporal arteritis ranges from approximately 0.5 to 27 cases per 100,000 people aged 50 years or older. The incidence of temporal arteritis increases with [[Ageing|age]]; the median [[age]] at diagnosis is 76.7 years. Temporal arteritis commonly affects individuals older than 70 years of age. Temporal arteritis usually affects individuals of the white race. Black, Asians, and Hispanic individuals are less likely to develop temporal arteritis. Women are more commonly affected by temporal arteritis than men. The [[female]] to [[male]] ratio is approximately 3 to 1. The highest incidence of temporal arteritis is reported in Scandanavian countries at 32.7 per 100,000 people for people over 50 years of age.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*Incidence of temporal arteritis ranges from approximately 0.5 to 27 cases per 100,000 people aged 50 years or older.<ref name="pmid1634709">{{cite journal| author=Goodwin JS| title=Progress in gerontology: polymyalgia rheumatica and temporal arteritis. | journal=J Am Geriatr Soc | year= 1992 | volume= 40 | issue= 5 | pages= 515-25 | pmid=1634709 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1634709  }} </ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
 
===Case-fatality rate/Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop [disease name].
*The incidence of temporal arteritis increases with age; the median age at diagnosis is 76.7 years.<ref name="pmid19854712">{{cite journal| author=Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Gabriel SE, Matteson EL et al.| title=Increase in age at onset of giant cell arteritis: a population-based study. | journal=Ann Rheum Dis | year= 2010 | volume= 69 | issue= 4 | pages= 780-1 | pmid=19854712 | doi=10.1136/ard.2009.111005 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19854712  }} </ref>
*The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
*Temporal arteritis commonly affects individuals older than 70 years of age.<ref name="pmid15077270">{{cite journal| author=Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE| title=Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. | journal=Arthritis Rheum | year= 2004 | volume= 51 | issue= 2 | pages= 264-8 | pmid=15077270 | doi=10.1002/art.20227 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15077270  }} </ref><ref name="pmid17435586">{{cite journal| author=Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A et al.| title=Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. | journal=Medicine (Baltimore) | year= 2007 | volume= 86 | issue= 2 | pages= 61-8 | pmid=17435586 | doi=10.1097/md.0b013e31803d1764 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17435586  }} </ref>
*[Disease name] commonly affects individuals younger than/older than [number of years] years of age.  
*[Chronic disease name] is usually first diagnosed among [age group].
*[Acute disease name] commonly affects [age group].


===Race===
===Race===
*There is no racial predilection to [disease name].
*Temporal arteritis usually affects individuals of the white race. Black, Asians, and Hispanic individuals are less likely to develop temporal arteritis.<ref name="pmid19790127">{{cite journal| author=Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J et al.| title=Epidemiology of giant cell arteritis and polymyalgia rheumatica. | journal=Arthritis Rheum | year= 2009 | volume= 61 | issue= 10 | pages= 1454-61 | pmid=19790127 | doi=10.1002/art.24459 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19790127  }} </ref><ref name="pmid12359586">{{cite journal| author=Artal NM, Rodriguez M, Luna JD, Reviglio VE, Cuello O, Muiñ JC et al.| title=Giant cell arteritis in a Hispanic population. | journal=Ophthalmology | year= 2002 | volume= 109 | issue= 10 | pages= 1757; discussion 1757 | pmid=12359586 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12359586  }} </ref>
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
 
===Gender===
===Gender===
*[Disease name] affects men and women equally.
*Women are more commonly affected by temporal arteritis than men. The female to male ratio is approximately 3 to 1.<ref name="pmid19790127">{{cite journal| author=Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J et al.| title=Epidemiology of giant cell arteritis and polymyalgia rheumatica. | journal=Arthritis Rheum | year= 2009 | volume= 61 | issue= 10 | pages= 1454-61 | pmid=19790127 | doi=10.1002/art.24459 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19790127  }} </ref>
*[Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
===Region===
*The majority of [disease name] cases are reported in [geographical region].


*[Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
=== Region ===
 
===Developed Countries===
 
===Developing Countries===
===Age===
The mean age of onset is about 70 years and is rare at less than 50 years of age.
 
Because temporal arteritis is a disease of the elderly, the prevalence of the disease is very dependent upon the age of the population. As a result, there is a lower prevalence in countries with a shorter or reduced life expectancy.
===Gender===
It is more common in females than males by a ratio of 3.7:1.
===Race===
It is more prevalent in caucasians.
===Prevalence===
Most likely as a result of increased clinical recognition of the syndrome, the incidence of temporal arteritis increased between 1950 and 1975 from 5.1 to 17.4 incident cases per 100,000 population per year in persons aged 50 years and older in Olmsted County, Minnesota. More recently in this population, the prevalence was even higher at 133 cases per 100,000 in persons aged 50 years and older.


There is not much data regarding the prevalence of disease outside the US, but given the variation in life expectancy and demographics, the prevalence is thought to vary significantly. The highest reported rates of disease outside the US are in Scandinavia, where the prevalence is 23.3-33.6 per 100,000 people older than 50 years.
====Developed Countries====
*The highest incidence of temporal arteritis is reported in Scandanavian countries at 32.7 per 100,000 people for people over 50 years of age.<ref name="Smeeth2006">{{cite journal|last1=Smeeth|first1=L|title=Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001|journal=Annals of the Rheumatic Diseases|volume=65|issue=8|year=2006|pages=1093–1098|issn=0003-4967|doi=10.1136/ard.2005.046912}}</ref>


==References==
==References==
Line 60: Line 32:
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Needs overview]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 03:01, 16 April 2018

Temporal Arteritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Temporal Arteritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Temporal arteritis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Temporal arteritis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Temporal arteritis epidemiology and demographics

CDC on Temporal arteritis epidemiology and demographics

Temporal arteritis epidemiology and demographics in the news

Blogs on Temporal arteritis epidemiology and demographics

Directions to Hospitals Treating Temporal arteritis

Risk calculators and risk factors for Temporal arteritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

Incidence of temporal arteritis ranges from approximately 0.5 to 27 cases per 100,000 people aged 50 years or older. The incidence of temporal arteritis increases with age; the median age at diagnosis is 76.7 years. Temporal arteritis commonly affects individuals older than 70 years of age. Temporal arteritis usually affects individuals of the white race. Black, Asians, and Hispanic individuals are less likely to develop temporal arteritis. Women are more commonly affected by temporal arteritis than men. The female to male ratio is approximately 3 to 1. The highest incidence of temporal arteritis is reported in Scandanavian countries at 32.7 per 100,000 people for people over 50 years of age.

Epidemiology and Demographics

Incidence

  • Incidence of temporal arteritis ranges from approximately 0.5 to 27 cases per 100,000 people aged 50 years or older.[1]

Age

  • The incidence of temporal arteritis increases with age; the median age at diagnosis is 76.7 years.[2]
  • Temporal arteritis commonly affects individuals older than 70 years of age.[3][4]

Race

  • Temporal arteritis usually affects individuals of the white race. Black, Asians, and Hispanic individuals are less likely to develop temporal arteritis.[5][6]

Gender

  • Women are more commonly affected by temporal arteritis than men. The female to male ratio is approximately 3 to 1.[5]

Region

Developed Countries

  • The highest incidence of temporal arteritis is reported in Scandanavian countries at 32.7 per 100,000 people for people over 50 years of age.[7]

References

  1. ↑ Goodwin JS (1992). "Progress in gerontology: polymyalgia rheumatica and temporal arteritis". J Am Geriatr Soc. 40 (5): 515–25. PMID 1634709.
  2. ↑ Kermani TA, Schäfer VS, Crowson CS, Hunder GG, Gabriel SE, Matteson EL; et al. (2010). "Increase in age at onset of giant cell arteritis: a population-based study". Ann Rheum Dis. 69 (4): 780–1. doi:10.1136/ard.2009.111005. PMID 19854712.
  3. ↑ Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE (2004). "Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period". Arthritis Rheum. 51 (2): 264–8. doi:10.1002/art.20227. PMID 15077270.
  4. ↑ Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez-Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A; et al. (2007). "Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study". Medicine (Baltimore). 86 (2): 61–8. doi:10.1097/md.0b013e31803d1764. PMID 17435586.
  5. ↑ 5.0 5.1 Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J; et al. (2009). "Epidemiology of giant cell arteritis and polymyalgia rheumatica". Arthritis Rheum. 61 (10): 1454–61. doi:10.1002/art.24459. PMID 19790127.
  6. ↑ Artal NM, Rodriguez M, Luna JD, Reviglio VE, Cuello O, Muiñ JC; et al. (2002). "Giant cell arteritis in a Hispanic population". Ophthalmology. 109 (10): 1757, discussion 1757. PMID 12359586.
  7. ↑ Smeeth, L (2006). "Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001". Annals of the Rheumatic Diseases. 65 (8): 1093–1098. doi:10.1136/ard.2005.046912. ISSN 0003-4967.

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Temporal_arteritis_epidemiology_and_demographics&oldid=1462853"